← All stocks

FEMASYS INC

FEMY Net buying
CIK 0001339005 #5009 in the set updated 18 Sep 2026
Bought (120 mo)
$2.74M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$2.74M
+$2.74M against sales at will

By person

11 insiders · 12 transactions
0.0×

Kathy Lee-Sepsick holds only 0.0 times base salary in stock. $50.00K of shares against $542.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kathy Lee-Sepsick last reported holding, valued at $3.20, the price Common Stock was last bought or sold at on the open market here, on 7 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Uzialko Edward R
Director
$1.30M (1)
+$1.30M
1,217,406
$3.90M
+4,281%
Dyett John
Director
$691.70K (4)
+$691.70K
3,627,348
$11.61M
+8.8%
Adams John Q JR
Director
$520.00K (1)
+$520.00K
239,938
$767.80K
Larsen Charles
Director
$91.00K (1)
+$91.00K
56
$179.16
Elefant Dov
Chief Financial Officer
$50.00K (1)
+$50.00K
15,625
$50.00K
Lee-Sepsick Kathy
Chief Executive Officer
$50.00K (1)
+$50.00K
15,625
$50.00K
Canning John Charles
Chief Operating Officer
$14.00K (1)
+$14.00K
4,375
$14.00K
Mifek Jeffrey Gerald
Chief Clinical-Medical Affairs
$10.00K (1)
+$10.00K
3,125
$10.00K
Sipos Jeremy Alexander
Chief Technology Officer
$10.00K (1)
+$10.00K
3,125
$10.00K
Currie Daniel Scott
Chief Operating Officer
86,275
$276.08K
+29.4%
Witte William Benson
Director
12,191
$39.01K

No percentages here. This company's share count has moved by a factor of 7.2 over the window, from 8,375,027 to 60,390,686 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Lee-Sepsick Kathy
7 Aug 2026
Chief Executive Officer
Buy
15,625
$3.20
$50.00K
Elefant Dov
7 Aug 2026
Chief Financial Officer
Buy
15,625
$3.20
$50.00K
Canning John Charles
7 Aug 2026
Chief Operating Officer
Buy
4,375
$3.20
$14.00K
Sipos Jeremy Alexander
7 Aug 2026
Chief Technology Officer
Buy
3,125
$3.20
$10.00K
Mifek Jeffrey Gerald
7 Aug 2026
Chief Clinical-Medical Affairs
Buy
3,125
$3.20
$10.00K
Dyett John
23 Jun 2021
Director
Buy indirect
1,000
$9.95
$9.95K
Dyett John
22 Jun 2021
Director
Buy indirect
40,000
$13.00
$520.00K
Adams John Q JR
22 Jun 2021
Director
Buy
40,000
$13.00
$520.00K
Larsen Charles
22 Jun 2021
Director
Buy
7,000
$13.00
$91.00K
Uzialko Edward R
22 Jun 2021
Director
Buy
100,000
$13.00
$1.30M
Dyett John
18 Jun 2021
Director
Buy indirect
10,000
$12.88
$128.80K
Dyett John
18 Jun 2021
Director
Buy indirect
2,500
$13.18
$32.95K

What was left out

Form 4 filings counted 75
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 8,176,673
History held since 24 Jun 2021